Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Massimi

Showing results (241-250 of 245) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 245 results.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort AnalysisVijay Ramaswamy, Thomas Hielscher, Stephen C Mack, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Pageof 25

Showing results (241-250 of 245) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 245 results.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort AnalysisVijay Ramaswamy, Thomas Hielscher, Stephen C Mack, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Pageof 25